All News

The verdicts and settlements involved in this case and 8 others.

A January 4th action by the US Food and Drug Administration (FDA) reclassified transvaginal mesh implants for pelvic organ prolapse (POP) as class III (or high-risk) medical devices requiring premarket approval application (PMA).

The study was designed for tight control of the usual variables.

If proven effective, the vaccine, called VGX-3100, would be the first non-ablative therapy for cervical precancer.

In high-risk patients, use of ultrasound for prenatal diagnosis of this anomaly can enable cesarean delivery and avoid rupture of fetal vessels.

A prospective cohort study looked at a possible link.

A population-based retrospective cohort study by researchers from Oregon is adding new data to the ongoing debate about the safety of giving birth outside of the hospital versus in the hospital.

This mosquito-borne virus is linked with microcephaly, but causation is still being investigated.

The organization finalizes the guidelines that were met with debate when they were first announced in 2015.

Dr Lockwood reflects on the potential challenges of 2016.

Surgical mesh for pelvic organ prolapse (POP) is a class III or high-risk medical device requiring premarket approval application (PMA) following new action by the Food and Drug Administration (FDA).

Did it occur during surgery, or did a later injury lead to it?

How did Ob/Gyn look in 2015? What did you love about your specialty and what frustrated you?

Early diagnosis, meticulous pre-op prep, and definitive extirpative surgery are key.

Mastering patient satisfaction measures and using them to guide operations decisions is a powerful practice management tool.

Monitors to keep track of fitness and health measures will help your patients.

A commentary on ACOG Practice Bulletin Number 151: Cytomegalovirus, Parvovirus B19, Varicella Zoster, and Toxoplasmosis in Pregnancy.

In the winter months, remain vigilant for CO poisoning, as the presenting signs are often nonspecific.

A look at whether or not oral contraceptives help with ovarian cancer survival. Plus: Do false-positive mammogram results serve as a sign of future breast cancer risk?

The key messages of Protocol 42: Preterm Labor.

A NASPAG study conducted at the University of Colorado finds that standardization is called for.

A new ACOG Committee Opinion stresses the importance of menstruation status as a part of the adolescent's medical history.

Forty-six ob/gyns, including members of the Contemporary OB/GYN board, have submitted an open letter to the US Food and Drug Administration regarding its communication on the safety of power morcellation.

A new study looks at whether high doses of some hormones are impeding IVF success. Plus: Do progesterone supplements help women with a history of unexplained recurrent pregnancy loss?

Human trafficking, or rather, modern slavery, is an insidious and pervasive problem in our society.

An overview of anti-epileptic drugs and their use during pregnancy, as well as other perinatal considerations for women with seizure disorders.

A recent trial reveals that ST-segment analysis does not improve CP rates.

Research looks at whether the Apgar score can be an indicator of maternal health as well. Plus: Do important reproductive milestones have an impact on long-term health? And, using another imaging tool for breast cancer detection.